The global artificial intelligence (AI) in healthcare Market size was USD 19.27 billion in 2023, estimated at USD 26.69 billion in 2024 and is anticipated to reach around USD 613.81 billion by 2034, expanding at a CAGR of 36.83% from 2024 to 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Artificial Intelligence (AI) in Healthcare Market
5.1. COVID-19 Landscape: Artificial Intelligence (AI) in Healthcare Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Artificial Intelligence (AI) in Healthcare Market, By Component
8.1. Artificial Intelligence (AI) in Healthcare Market, by Component Type, 2024-2034
8.1.1. Software
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Hardware
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Artificial Intelligence (AI) in Healthcare Market, By Application
9.1. Artificial Intelligence (AI) in Healthcare Market, by Application, 2024-2034
9.1.1. Virtual Assistants
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Diagnosis
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Robot Assisted Surgery
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Clinical Trials
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Wearables
9.1.5.1. Market Revenue and Forecast (2021-2034)
9.1.6. Administrative Workflow Assistants
9.1.6.1. Market Revenue and Forecast (2021-2034)
9.1.7. Cybersecurity
9.1.7.1. Market Revenue and Forecast (2021-2034)
9.1.8. Dosage Error Reduction
9.1.8.1. Market Revenue and Forecast (2021-2034)
9.1.9. Fraud Detection
9.1.9.1. Market Revenue and Forecast (2021-2034)
9.1.10. Connected Machines
9.1.10.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Artificial Intelligence (AI) in Healthcare Market, By Technology Type
10.1. Artificial Intelligence (AI) in Healthcare Market, by Technology Type, 2024-2034
10.1.1. Machine Learning
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Natural Language Processing
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Context-aware Computing
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Computer Vision
10.1.4.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global Artificial Intelligence (AI) in Healthcare Market, By End User Type
11.1. Artificial Intelligence (AI) in Healthcare Market, by End User Type, 2024-2034
11.1.1. Hospital & Healthcare Providers
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Patients
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Pharmaceuticals & Biotechnology Companies
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Healthcare Payers
Chapter 12. Global Artificial Intelligence (AI) in Healthcare Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Component (2021-2034)
12.1.2. Market Revenue and Forecast, by Application (2021-2034)
12.1.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.1.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Component (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.1.5.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Component (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.1.6.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Component (2021-2034)
12.2.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.2.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Component (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.2.5.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Component (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.2.6.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Component (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.2.7.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Component (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.2.8.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Component (2021-2034)
12.3.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.3.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Component (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.3.5.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Component (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.3.6.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Component (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.3.7.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Component (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.3.8.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Component (2021-2034)
12.4.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.4.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Component (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.4.5.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Component (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.4.6.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Component (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.4.7.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Component (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.4.8.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Component (2021-2034)
12.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.5.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.5.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Component (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.5.5.4. Market Revenue and Forecast, by End User Type (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Component (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Technology Type (2021-2034)
12.5.6.4. Market Revenue and Forecast, by End User Type (2021-2034)
Chapter 13. Company Profiles
13.1. Intel
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Koninklijke Philips
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Microsoft
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. IBM
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Siemens Healthineers
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Nvidia
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Google
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. General Electric Company
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Medtronic
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Micron Technology
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
13.11. Amazon Web Services
13.11.1. Company Overview
13.11.2. Product Offerings
13.11.3. Financial Performance
13.11.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client